Safety study of centanafadine in Binge-Eating disorders
This study is completed in the United States. It is testing centanafadine for Binge-Eating disorders.
Eating disorders, Binge-Eating disordersDrugFrom 18 Years to 65 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Centanafadine may be useful for adults experiencing eating disorders.
What would participation involve?
Participants may receive Centanafadine, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.
Who is it mainly for?
This study appears to be mainly for adults with eating disorders.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: December 22, 2021
Recruitment status
Completed
Enrollment listed in the registry
147
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT05113953
Official title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets After Oral Administration in Adult Subjects With Binge Eating Disorder
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United States · 25 sites
NoesisPharma, LLC
Phoenix, Arizona
Site status: Not listed — confirm with the team
Southern California Research LLC
Beverly Hills, California
Site status: Not listed — confirm with the team
Pharmacology Research Institute - San Fernando Valley
Encino, California
Site status: Not listed — confirm with the team
Collaborative Neuroscience Research, LLC
Garden Grove, California
Site status: Not listed — confirm with the team
Pacific Clinical Research Management Group LLC
Upland, California
Site status: Not listed — confirm with the team
Mountain View Clinical Research, LLC
Denver, Colorado
Site status: Not listed — confirm with the team
Clinical Neuroscience Solutions - Jacksonville
Jacksonville, Florida
Site status: Not listed — confirm with the team
Miami Dade Medical Research Institute
Miami, Florida
Site status: Not listed — confirm with the team
iResearch Atlanta
Decatur, Georgia
Site status: Not listed — confirm with the team
Psych Atlanta, PC
Marietta, Georgia
Site status: Not listed — confirm with the team
Psychiatric Associates
Overland Park, Kansas
Site status: Not listed — confirm with the team
Collective Medical Research
Prairie Village, Kansas
Site status: Not listed — confirm with the team
Boston Clinical Trials
Boston, Massachusetts
Site status: Not listed — confirm with the team
St. Charles Psychiatric Associates & Midwest Research Group
Weldon Spring, Missouri
Site status: Not listed — confirm with the team
ActivMed Practices and Research - Portsmouth
Portsmouth, New Hampshire
Site status: Not listed — confirm with the team
Center for Emotional Fitness
Cherry Hill, New Jersey
Site status: Not listed — confirm with the team
Princeton Medical Institute
Princeton, New Jersey
Site status: Not listed — confirm with the team
Manhattan Behavioral Medicine
New York, New York
Site status: Not listed — confirm with the team
Medical Research Network, LLC
New York, New York
Site status: Not listed — confirm with the team
Richmond Behavioral Associates
Staten Island, New York
Site status: Not listed — confirm with the team
Midwest Clinical Research Center
Dayton, Ohio
Site status: Not listed — confirm with the team
Craig and Frances Linder Center of Hope
Mason, Ohio
Site status: Not listed — confirm with the team
Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee
Site status: Not listed — confirm with the team
Psychiatry + Psychotherapy Partners Austin
Austin, Texas
Site status: Not listed — confirm with the team
FutureSearch Trials - Dallas
Dallas, Texas
Site status: Not listed — confirm with the team
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT05113953. We help you review the study, but cannot decide medical eligibility.
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with eating disorders. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Centanafadine, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Who might this study be for?
This study may concern people with eating disorders; age range: From 18 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc., which appears to be a pharmaceutical company. Sponsor website: https://www.otsuka.co.jp/en/. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
